# Publications

Wu, X., Islam, S., Oien, D.B., Tokheim, C., Beacom, A., Aryal, N., Hsueh, M., **Floren, M.**, Ross-Thriepland, D., Barrell, D. and McDermott, U. (2023). A Multi-Modal Analysis of Acquired Resistance to Acalabrutinib and Pirtobrutinib Provides Potential Strategies to Augment Treatment Outcome with BTKi Drugs. Blood, 142, 1452.

Shah, R., Wander, H., Hsueh, M., **Floren, M.**, Liu, W., Cheung, P., ... & Auclair, D. (2024). Multiplexed flow cytometry based immunophenotyping paired with functional ex vivo (MFLEX) drug profiling informs potential efficacy of therapeutic agents in acute myeloid leukemia. *Cancer Research*, 84(6_Supplement), 3904-3904.

Pascetti, E.M., Restrepo-Cruz, S., **Floren, M.**, Saito-Reis, C.A., Balise, V.D. and Gillette, J.M., 2021. Tetraspanin CD82 Regulates Hematopoietic Stem and Progenitor Cell Quiescence and Regeneration. *Blood*, 138(Supplement 1), pp.3264-3264.

**Muskan Floren**, Jennifer M. Gillette. 2021. "Acute myeloid leukemia: Therapy resistance and a potential role for tetraspanin membrane scaffolds", *The International Journal of Biochemistry & Cell Biology*. [(full paper)](https://www.sciencedirect.com/science/article/pii/S1357272521001072)

**Floren, M.**, S. Restrepo Cruz, C. M. Termini, K. D. Marjon, K. A. Lidke, and J. M. Gillette. 2020. "Tetraspanin CD82 drives acute myeloid leukemia chemoresistance by modulating protein kinase C alpha and beta1 integrin activation", *Oncogene*. [(full paper)](https://www.nature.com/articles/s41388-020-1261-0)

Saito-Reis, C. A., K. D. Marjon, E. M. Pascetti, **M. Floren**, and J. M. Gillette. 2018. "The tetraspanin CD82 regulates bone marrow homing and engraftment of hematopoietic stem and progenitor cells", *Molecular Biology of the Cell*, 29: 2946-58.

O'Donnell, P., J. Shyu, J. Ferguson, K. Demartin, T. May, D. Jensen, M. Celeri, T. Rehage, L. Corona, R. Current, S. Joshi, Y. Wu, **M. Floren**, and S. Soviero. 2016. "A Real-time PCR Assay for the Detection of EGFR Mutations in FFPE Tissue and Plasma Samples of NSCLC Patients", *Journal of Clinical Oncology*, 34: e23251-e51.

Turk-Kubo, K. A., **M. Karamchandani**, D. G. Capone, and J. P. Zehr. 2014. "The paradox of marine heterotrophic nitrogen fixation: abundances of heterotrophic diazotrophs do not account for nitrogen fixation rates in the Eastern Tropical South Pacific", *Environmental Microbiology*, 16: 3095-114.

# Oral Presentations
* **M.Floren**, E.M. Pascetti, J.M. Gillette. “Impact of the CD82 scaffold on Acute Myeloid Leukemia chemosensitivity and niche interactions.” Biomedical Sciences Graduate Program Student Research Day. Albuquerque, NM. March 2020
* **M.Floren**, K.D. Marjon, C.M. Termini, J.M. Gillette. “Impact of the CD82 scaffold on Acute Myeloid Leukemia/ niche interactions and chemosensitivity.” UNM Cancer Research Day. Albuquerque, NM. November 2019
* **M.Floren**, K.D. Marjon, C.M. Termini, J.M. Gillette. “CD82 expression promotes acute myeloid leukemia chemoresistance and Relapse.” UNM STEM Research Symposium. Albuquerque, NM. March 2019
* **M.Floren**, K.D. Marjon, C.M. Termini, J.M. Gillette. “Impact of the CD82 scaffold on Acute Myeloid Leukemia/ niche interactions and chemosensitivity.” 2018 ASCB Doorstep Meeting. San Diego, CA. December 2018.
* **M.Floren**, K.D. Marjon, C.M. Termini, J.M. Gillette. “Impact of CD82 expression in acute myeloid leukemia chemoresistance and disease Relapse.” UNM Pathology Seminar Series. Albuquerque, NM. August 2018
* **M.Floren**, K.D. Marjon, C.M. Termini, J.M. Gillette. “CD82 expression promotes acute myeloid leukemia chemoresistance.” UNM Cancer Research Day. Albuquerque, NM. May 2018. 
* **M.Floren**, K.D. Marjon, C.M. Termini, J.M. Gillette. “CD82 expression promotes acute myeloid leukemia * M.Floren, K.D. Marjon, C.M. Termini, J.M. Gillette. “Role of CD82 expression in acute myeloid leukemia” Spatiotemporal Modeling Center Seminar. Albuquerque, NM. December 2017. 

# Poster Presentations

* **M.Floren**, E.M. Pascetti, J.M. Gillette. “The Membrane Scaffold CD82 Regulates Acute Myeloid Leukemia Dormancy and Bone Marrow Niche Interactions.” American Society of Hematology. Orlando, FL. December 2019
* **M.Floren**, C.M. Termini, K.D. Marjon, J.M. Gillette. “CD82 expression promotes acute myeloid leukemia chemoresistance.” American Society for Cell Biology Annual Meeting. San Diego, CA. December 2018.
* **M.Floren**, K.D. Marjon, C.M. Termini, J.M. Gillette. “ Role of CD82 expression in acute myeloid leukemia chemoresistance.” UNM Cancer Research Day.  Albuquerque, NM. May 2018. 
* **M.Floren**, K.D. Marjon, C.M. Termini, J.M. Gillette. “ Role of CD82 expression in acute myeloid leukemia chemoresistance.” International Tetraspanin Scaffolding Research Conference. Tucson, Az. April 2018. 
* **M.Floren**, K.D. Marjon, C.M. Termini, J.M. Gillette. “CD82 expression promotes acute myeloid leukemia chemoresistance.” American Society for Cell Biology Annual Meeting. Philadelphia, PA. December 2017. 
* **M.Floren**, K.D. Marjon, C.M. Termini, J.M. Gillette. “CD82 expression promotes acute myeloid leukemia niche adhesion 
* Ganguly A., Rangaraj K., **Karamchandani M.**, Cheng P., Virdi A. “A Novel Modified Green Approach to the Oxidation of Alcohols.” 187th Annual conference of the American Chemical Society, San Francisco, CA. March 2010
